May 28, 2019
2 min read
Save

Patients with high tension glaucoma progressed faster than primary angle closure

Rates of visual field progression were found to be faster in patients with high tension glaucoma than in those with primary angle closure glaucoma, at similar baseline severity.

Perspective from Lisa M. Young, OD, FAAO

Patient compliance and follow-up are essential determinates for glaucoma treatment outcome in regular clinical care, according to a study recently published in Investigative Ophthalmology & Visual Science.

The authors stated that while clinical trials typically monitor IOP control, compliance and follow-up, progression rates obtained this way may not reflect those of patients receiving regular clinic care.

Researchers conducted this retrospective study using the data of patients with a clinical diagnosis of high tension glaucoma (HTG, n = 310), primary angle closure glaucoma (PACG, n = 304) and normal tension glaucoma (NTG, n = 165) with five or more visual field exams between January 2000 and December 2012.

Matching visual fields for a baseline measurement for progression, researchers compared each glaucoma subtype as well as the age of the individual. They also measured scotoma expansion and scotoma deepening within the three visual field zones: superior arcuate, inferior arcuate and central.

Researchers found that more HTG eyes presented with significant visual field progression compared with the PACG eyes. However, the difference between the number of progressing eyes with HTG and NTG was not statistically significant, and neither was the difference between NTG and PCAG.

According to the study results, when the individual baseline visual fields were matched by age, disease progression was similar across all of the subtypes.

The scotoma deepening (SD) and expansion (SE) in the superior arcuate zone was greater in the HTG and NTG eyes. PACG eyes presented with greater SD and SE in the inferior arcuate zone than the other subtypes.

Researchers concluded that patients with HTG receiving clinical care from glaucoma specialists presented with a faster visual field progression than those with PACG or NTG subtypes. – by Scott Buzby

Disclosure: The authors report no relevant financial disclosures.